PRECLINICAL CHARACTERIZATION OF NOVEL CYCLOPHILIN INHIBITORS BASED ON THE POLYKETIDE, SANGLIFEHRIN

被引：0

作者：

Moss, S. J. ^{[2
]}

Bobardt, M. ^{[1
]}

Coates, N. ^{[2
]}

Chatterji, U. ^{[1
]}

Foster, T. ^{[2
]}

Gallay, P. ^{[1
]}

Habel, A. ^{[2
]}

Kendrew, S. ^{[2
]}

Leyssen, P. ^{[3
]}

Martin, C. J. ^{[2
]}

Neyts, J. ^{[3
]}

Nur-e-Alam, M. ^{[2
]}

Obeid, S. ^{[3
]}

Paeshuyse, J. ^{[3
]}

Suthar, D. ^{[2
]}

Warneck, T. ^{[2
]}

Wilkinson, B. ^{[2
]}

Gregory, M. A. ^{[2
]}

机构：

[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA

[2] Biot Technol Ltd, Cambridge, England

[3] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

10.1016/S0168-8278(11)60791-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

789

引用

页码：S317 / S317

页数：1

共 50 条

[1] Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family
Gregory, Matthew A.
Bobardt, Michael
Obeid, Susan
Chatterji, Udayan
Coates, Nigel J.
Foster, Teresa
Gallay, Philippe
Leyssen, Pieter
Moss, Steven J.
Neyts, Johan
Nur-e-Alam, Mohammad
Paeshuyse, Jan
Piraee, Mahmood
Suthar, Dipen
Warneck, Tony
Zhang, Ming-Qiang
Wilkinson, Barrie
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 1975 - 1981
[2] Activity of Novel Cyclophilin Inhibitors based on the Polyketide, Sanglifehrin A, against HIV
Bobardt, Michael
Moss, Steven
Chatterji, Udayan
Nur-E-Alam, Mohammad
Warneck, Tony
Wilkinson, Barrie
Gallay, Philippe
Gregory, Matthew
[J]. ANTIVIRAL RESEARCH, 2011, 90 (02) : A29 - A29
[3] Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Steadman, Victoria A.
Pettit, Simon B.
Poullennec, Karine G.
Lazarides, Linos
Keats, Andrew J.
Dean, David K.
Stanway, Steven J.
Austin, Carol A.
Sanvoisin, Jonathan A.
Watt, Gregory M.
Fliri, Hans G.
Liclican, Albert C.
Jin, Debi
Wong, Melanie H.
Leavitt, Stephanie A.
Lee, Yu-Jen
Tian, Yang
Frey, Christian R.
Appleby, Todd C.
Schmitz, Uli
Jansa, Petr
Mackman, Richard L.
Schultz, Brian E.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (03) : 1000 - 1017
[4] Structure of human cyclophilin a in complex with the novel immunosuppressant sanglifehrin a at 1.6 Å resolution
Kallen, J
Sedrani, R
Zenke, G
Wagner, J
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) : 21965 - 21971
[5] Cloning, sequencing and characterization of the biosynthetic gene cluster of sanglifehrin A, a potent cyclophilin inhibitor
Qu, Xudong
Jiang, Nan
Xu, Fei
Shao, Lei
Tang, Gongli
Wilkinson, Barrie
Liu, Wen
[J]. MOLECULAR BIOSYSTEMS, 2011, 7 (03) : 852 - 861
[6] From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds
Sweeney, Zachary K.
Fu, Jiping
Wiedmann, Brigitte
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (17) : 7145 - 7159
[7] NICAMs: Development of novel cyclosporine-based cyclophilin inhibitors
Trepanier, Dan
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[8] Synthesis of derivatives of the novel cyclophilin-binding immunosuppressant sanglifehrin A with reduced numbers of polar functions
Bänteli, R
Wagner, J
Zenke, G
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (12) : 1609 - 1612
[9] Anti-fibrotic effect of NV556, a sanglifehrin-based cyclophilin inhibitor, in a preclinical model of non-alcoholic steatohepatitis
Gronberg, A.
Elmer, E.
Gregory, M.
Moss, S.
Hansson, M.
[J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S162 - S163
[10] Novel inhibitors of HIF prolyl hydroxylase and their preclinical characterization
Khristichenko, A.
Smirnova, N.
Andrey, O.
Zakhariants, A.
Gazaryan, I.
Tonevitsky, A.
Poloznikov, A.
[J]. FEBS OPEN BIO, 2018, 8 : 251 - 251

← 1 2 3 4 5 →